171 related articles for article (PubMed ID: 34398431)
21. Investigation of PAX3/7-FKHR fusion genes and IGF2 gene expression in rhabdomyosarcoma tumors.
de Souza RR; Oliveira ID; Caran EM; Alves MT; Abib S; Toledo SR
Growth Horm IGF Res; 2012 Dec; 22(6):245-9. PubMed ID: 23079386
[TBL] [Abstract][Full Text] [Related]
22. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
Kelly KM; Womer RB; Sorensen PH; Xiong QB; Barr FG
J Clin Oncol; 1997 May; 15(5):1831-6. PubMed ID: 9164192
[TBL] [Abstract][Full Text] [Related]
23. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
[TBL] [Abstract][Full Text] [Related]
24. Upstream CpG island methylation of the PAX3 gene in human rhabdomyosarcomas.
Kurmasheva RT; Peterson CA; Parham DM; Chen B; McDonald RE; Cooney CA
Pediatr Blood Cancer; 2005 Apr; 44(4):328-37. PubMed ID: 15602708
[TBL] [Abstract][Full Text] [Related]
25. Congenital spindle cell rhabdomyosarcoma.
Whittle SB; Hicks MJ; Roy A; Vasudevan SA; Reddy K; Venkatramani R
Pediatr Blood Cancer; 2019 Nov; 66(11):e27935. PubMed ID: 31339226
[TBL] [Abstract][Full Text] [Related]
26. Congenital rhabdomyosarcoma: A report from the European paediatric Soft tissue sarcoma Study Group.
Bisogno G; Minard-Colin V; Arush MB; Daragjati J; Coppadoro B; Gallego S; Alaggio R; Smeulders N; Mudry P; Zin A; Merks JHM; Slater O
Pediatr Blood Cancer; 2022 Feb; 69(2):e29376. PubMed ID: 34582098
[TBL] [Abstract][Full Text] [Related]
27. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
[TBL] [Abstract][Full Text] [Related]
28. Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma.
Krsková L; Mrhalová M; Hilská I; Sumerauer D; Drahokoupilová E; Múdry P; Kodet R
Virchows Arch; 2010 May; 456(5):463-72. PubMed ID: 20405298
[TBL] [Abstract][Full Text] [Related]
29. A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases.
Alaggio R; Zhang L; Sung YS; Huang SC; Chen CL; Bisogno G; Zin A; Agaram NP; LaQuaglia MP; Wexler LH; Antonescu CR
Am J Surg Pathol; 2016 Feb; 40(2):224-35. PubMed ID: 26501226
[TBL] [Abstract][Full Text] [Related]
30. Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: focus on MYCN as a biologically relevant target.
Mercado GE; Xia SJ; Zhang C; Ahn EH; Gustafson DM; Laé M; Ladanyi M; Barr FG
Genes Chromosomes Cancer; 2008 Jun; 47(6):510-20. PubMed ID: 18335505
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum.
Le Loarer F; Laffont S; Lesluyes T; Tirode F; Antonescu C; Baglin AC; Delespaul L; Soubeyran I; Hostein I; Pérot G; Chibon F; Baud J; Le Guellec S; Karanian M; Costes-Martineau V; Castain C; Eimer S; Le Bail B; Wassef M; Coindre JM
Am J Surg Pathol; 2019 Jun; 43(6):747-754. PubMed ID: 30829729
[TBL] [Abstract][Full Text] [Related]
32. Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.
Butel T; Karanian M; Pierron G; Orbach D; Ranchere D; Cozic N; Galmiche L; Coulomb A; Corradini N; Lacour B; Proust S; Guerin F; Boutroux H; Rome A; Mansuy L; Vérité C; Defachelles AS; Tirode F; Minard-Colin V
Cancer Med; 2020 Apr; 9(8):2698-2709. PubMed ID: 32087612
[TBL] [Abstract][Full Text] [Related]
33. Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma?
Blakely ML; Lobe TE; Anderson JR; Donaldson SS; Andrassy RJ; Parham DM; Wharam MD; Qualman SJ; Wiener ES; Grier HE; Crist WM
J Pediatr Surg; 1999 May; 34(5):736-41; discussion 741-2. PubMed ID: 10359174
[TBL] [Abstract][Full Text] [Related]
34. Molecular diagnostics in the management of rhabdomyosarcoma.
Arnold MA; Barr FG
Expert Rev Mol Diagn; 2017 Feb; 17(2):189-194. PubMed ID: 28058850
[TBL] [Abstract][Full Text] [Related]
35. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
[TBL] [Abstract][Full Text] [Related]
36. Importance of histopathological analysis and molecular genetics in a rare neonatal case of rhabdomyosarcoma.
Gramp P; Zappala T; Von Schuckmann L; Payton D; Wheller L
Australas J Dermatol; 2022 Aug; 63(3):380-384. PubMed ID: 35500145
[TBL] [Abstract][Full Text] [Related]
37. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
Baker KS; Anderson JR; Link MP; Grier HE; Qualman SJ; Maurer HM; Breneman JC; Wiener ES; Crist WM
J Clin Oncol; 2000 Jun; 18(12):2427-34. PubMed ID: 10856103
[TBL] [Abstract][Full Text] [Related]
38. Embryonal and alveolar rhabdomyosarcoma of parameningeal sites in adults: a report of 13 cases.
Montone KT; Barr FG; Zhang PJ; Feldman MD; LiVolsi VA
Int J Surg Pathol; 2009 Feb; 17(1):22-30. PubMed ID: 18945709
[TBL] [Abstract][Full Text] [Related]
39. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.
Seki M; Nishimura R; Yoshida K; Shimamura T; Shiraishi Y; Sato Y; Kato M; Chiba K; Tanaka H; Hoshino N; Nagae G; Shiozawa Y; Okuno Y; Hosoi H; Tanaka Y; Okita H; Miyachi M; Souzaki R; Taguchi T; Koh K; Hanada R; Kato K; Nomura Y; Akiyama M; Oka A; Igarashi T; Miyano S; Aburatani H; Hayashi Y; Ogawa S; Takita J
Nat Commun; 2015 Jul; 6():7557. PubMed ID: 26138366
[TBL] [Abstract][Full Text] [Related]
40. Predictors of clinical outcome in pediatric oligodendroglioma: meta-analysis of individual patient data and multiple imputation.
Wang KY; Vankov ER; Lin DDM
J Neurosurg Pediatr; 2018 Feb; 21(2):153-163. PubMed ID: 29192869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]